SANGAMO THERAPEUTICS INC (SGMO)

US8006771062 - Common Stock

1.13  +0.03 (+2.73%)

After market: 1.1015 -0.03 (-2.52%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
201.40M111.30M110.70M118.20M102.40M
Minority Interest Expense
N/A0.000.00100.00K200.00K
Operating Expenses
308.70M312.60M294.00M247.70M207.60M
Research and Development
245.40M249.90M230.80M180.60M145.90M
Selling, General, and Administrative Expenses
63.20M62.70M63.20M67.10M61.70M
Operating Income
-107.40M-201.30M-183.30M-129.60M-105.20M
Interest Income/Expense
13.30M9.40M5.30M8.80M9.80M
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-254.10M-191.80M-178.00M-120.80M-95.40M
Income Tax
-4.50M400.00K300.00K300.00K0.00
Net Income
-249.60M-192.30M-178.30M-121.00M-95.20M
EBITDA
-90.90M-189.20M-173.90M-123.90M-95.60M
 
Per Share Data
EPS Diluted Total Ops
-1.45-1.25-1.23-0.90-0.85
Non GAAP EPS
-1.45-1.25-1.24-0.93-0.84
 
Statistics
Profit Margin
-123.93%-172.78%-161.07%-102.37%-92.97%
Operating Profit Margin
-53.33%-180.86%-165.58%-109.64%-102.73%

All data in USD

Charts